Annals of Pharmacotherapy · 1992 · 52 citations · 5 references
MedicineDermatologyPharmacotherapyNeuropharmacologyPsychoneuroimmunologyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDepression PharmacotherapySerotonergic PharmacologyDrug-induced PsoriasisEtiologic HypothesisLithium TreatmentPsoriasis ImmunopathologyPsoriatic DiseaseSerotonergic MechanismsSerotonergic Modulation
BACKGROUND: A number of medications have been reported to induce psoriasis. We report two cases of fluoxetine-related psoriasis and discuss similarities between lithium-, trazodone hydrochloride-, and fluoxetine-induced psoriasis. OBSERVATIONS: Two women being treated for depression with fluoxetine developed psoriasis after 6 and 12 months' exposure. This time frame is clinically similar to that observed with lithium-induced psoriasis. CONCLUSIONS: The occurrence of lithium- and fluoxetine-induced psoriasis may not be random. Both drugs modulate serotonergic function, a factor that may contribute to the pathophysiology of psoriasis. If a patient on acute or long-term fluoxetine therapy develops psoriasis, the drug should be considered as a possible etiologic agent.
5
The side effect profile and safety of fluoxetine.
Wernicke Jf · PubMed · 1985 · 181 citations
Psoriasis and psychiatry: An update
Madhulika A. Gupta, Aditya K. Gupta, Herbert F. Haberman · General Hospital Psychiatry · 1987 · 92 citations
Manual of Dermatologic Therapeutics.
Annals of Internal Medicine · 1975 · 70 citations
Lithium, leukocytes, and lesions
Victor J. Selmanowitz · Clinics in Dermatology · 1986 · 15 citations